Plasma TAFI Antigen Variations in Healthy Subjects
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
1995 • 684 citations
TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
1996 • 641 citations
Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.
1991 • 381 citations
The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
1996 • 294 citations
Plasma carboxypeptidases as regulators of the plasminogen system.
1995 • 258 citations
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
1997 • 234 citations
Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of Coagulation
1998 • 223 citations
On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B
1997 • 212 citations
Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma
1996 • 211 citations
An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits
1989 • 153 citations
Characterisation of a Carboxypeptidase in Human Serum Distinct from Carboxypeptidase N
1989 • 152 citations
Inducible Carboxypeptidase Activity
1996 • 97 citations
An Antifibrinolytic Mechanism Describing the Prothrombotic Effect Associated with Factor VLeiden
1996 • 86 citations
Assay of Procarboxypeptidase U, a Novel Determinant of the Fibrinolytic Cascade, in Human Plasma
1999 • 80 citations
Daytime Fluctuations of Plasminogen Activator Inhibitor 1 (PAI-1) in Populations with High PAI-1 Levels
1992 • 36 citations